Canada Pension Plan Investment Board
XERS icon

Canada Pension Plan Investment Board’s Xeris Biopharma Holdings XERS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
374,800
-15,800
-4% -$105K ﹤0.01% 895
2025
Q4 		$3.07M Buy
390,600
+14,900
+4% +$117K ﹤0.01% 868
2025
Q3 		$3.06M Buy
+375,700
New +$2.5M ﹤0.01% 836

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canada Pension Plan Investment Board's XERS Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its Xeris Biopharma Holdings (XERS) stake by 4% in Q1 2026, selling an estimated $105K and leaving 374,800 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Canada Pension Plan Investment Board first reported a position in XERS in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.07M in Q4 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Canada Pension Plan Investment Board held 374,800 shares of Xeris Biopharma Holdings worth $2.17M as of Q1 2026.
  • Canada Pension Plan Investment Board sold 15,800 Xeris Biopharma Holdings shares in Q1 2026, an estimated $105K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #895 holding.
  • Canada Pension Plan Investment Board first reported a position in Xeris Biopharma Holdings in Q3 2025 and has held it in 3 quarters since.
  • Canada Pension Plan Investment Board's Xeris Biopharma Holdings position peaked at $3.07M in Q4 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.